Resource Type

Journal Article 446

Year

2024 1

2023 40

2022 29

2021 38

2020 37

2019 25

2018 15

2017 17

2016 21

2015 25

2014 23

2013 26

2012 20

2011 18

2010 18

2009 24

2008 20

2007 18

2006 4

2005 3

open ︾

Keywords

humic acid 9

biodiesel 5

2 4

stability 4

type 2 diabetes 4

type 2 diabetes mellitus 4

1 3

Adsorption 3

cancer immunotherapy 3

obesity 3

β-glucuronidase 2

ACE2 2

COVID-19 2

China 2

Chinese 2

Clinical trial 2

Denitrifying phosphorus removal 2

SARS-CoV-2 2

adsorption 2

open ︾

Search scope:

排序: Display mode:

Putative Mode of Action of the Monoterpenoids Linalool, Methyl Eugenol, Estragole, and Citronellal on Ligand-Gated Ion Channels Article

Amy S. Li, Akimasa Iijima, Junhao Huang, Qing X. Li, Yongli Chen

Engineering 2020, Volume 6, Issue 5,   Pages 541-545 doi: 10.1016/j.eng.2019.07.027

Abstract: It is well-known that the γ-aminobutyric acid type A receptors (GABAARs) and nicotinicacetylcholine receptor (nAChR) are primary molecular targets of the synthetic insecticides used in thenon-competitive inhibitor on GABAAR, as the half-maximal effective concentration values of γ-aminobutyricacid (GABA) for the rat α1β3γ2L GABAAR were not affected by LL: (36.2 ±

Keywords: Essential oil     γ-aminobutyric acid type A receptor     Linalool     Monoterpenoid     Nicotinic acetylcholinereceptor    

Protective effects of nicotine on gamma-aminobutyric acid neurons and dopaminergic neurons in mice with

Lei FU MD , Dezheng GONG BM , Yan PENG , Dongmei WANG BM , Hong XU , Yue LI MD , Dengqin YU BS , Yanhui FENG MD , Shengming YIN PhD , Jin GONG , Yiping SUN PhD ,

Frontiers of Medicine 2009, Volume 3, Issue 3,   Pages 330-335 doi: 10.1007/s11684-009-0051-4

Abstract: Tyrosine hydroxylase (TH) and γ-aminobutyric acid (GABA) were determined by using the immunocytochemistryNicotine has protective effects on the γ-aminobutyric acid neurons and dopaminergic neurons in the

Keywords: Parkinson disease     nicotine     dopaminergic neuron     gamma-aminobutyric acid neuron    

Plasma soluble C-type lectin-like receptor-2 is associated with the risk of coronary artery disease

Min Fei, Li Xiang, Xichen Chai, Jingchun Jin, Tao You, Yiming Zhao, Changgeng Ruan, Yiwen Hao, Li Zhu

Frontiers of Medicine 2020, Volume 14, Issue 1,   Pages 81-90 doi: 10.1007/s11684-019-0692-x

Abstract: Accumulating evidence suggests that C-type lectin-like receptor-2 (CLEC-2) plays an important role in

Keywords: soluble C-type lectin-like receptor-2     coronary artery disease     risk factor    

Chemotactic effect of urokinase-type plasminogen activator on mouse spermatozoa

DING Xiaofang, LI Honggang, XIONG Chengliang

Frontiers of Medicine 2008, Volume 2, Issue 2,   Pages 195-199 doi: 10.1007/s11684-008-0037-7

Abstract: The aim of this study is to investigate the chemotactic effect of urokinase-type plasminogen activatorTaken together, the results suggest that uPA can induce sperm chemotaxis by binding to its receptor

Keywords: chemotactic activity     receptor     uPA inhibitor     F10     chemoattractant    

Bioactive hyaluronic acid fragments inhibit lipopolysaccharide-induced inflammatory responses via theToll-like receptor 4 signaling pathway

Na You, Sasa Chu, Binggang Cai, Youfang Gao, Mizhou Hui, Jin Zhu, Maorong Wang

Frontiers of Medicine 2021, Volume 15, Issue 2,   Pages 292-301 doi: 10.1007/s11684-020-0806-5

Abstract: The high- and the low-molecular weight hyaluronic acids (HMW-HA and LMW-HA, respectively) showed different biological activities in inflammation. However, the role of LMW-HA in inflammatory response is controversial. In this study, we aimed to investigate the effect of bioactive hyaluronan (B-HA) on lipopolysaccharide (LPS)-induced inflammatory responses in human macrophages and mice. B-HA was produced from HA treated with glycosylated recombinant human hyaluronidase PH20. Human THP-1 cells were induced to differentiate into macrophages. THP-1-derived macrophages were treated with B-HA, LPS, or B-HA+LPS. The mRNA expression and the production of inflammatory cytokines were determined using quantitative real-time PCR and enzyme-linked immunosorbent assay. The phosphorylation levels of proteins in the nuclear factor- B (NF- B), mitogen-activated protein kinase (MAPK), and IRF-3 signaling pathways were measured using Western blot. The efficacy of B-HA was assessed in a mouse model of LPS-induced inflammation. Results showed that B-HA inhibited the expression of TNF-α, IL-6, IL-1, and IFN-β, and enhanced the expression of the anti-inflammatory cytokine IL-10 in LPS-induced inflammatory responses in THP-1-derived macrophages and . B-HA significantly suppressed the phosphorylation of the TLR4 signaling pathway proteins p65, IKKα/β, I Bα, JNK1/2, ERK1/2, p38, and IRF-3. In conclusion, our results demonstrated that the B-HA attenuated the LPS-stimulated inflammatory response by inhibiting the activation of the TLR4 signaling pathway. B-HA could be a potential anti-inflammatory drug in the treatment of inflammatory disease.

Keywords: bioactive hyaluronan     lipopolysaccharide     inflammatory cytokines     TLR4     human macrophages    

CHARACTERISTICS OF HERBIVORY/WOUND-ELICITED ELECTRICAL SIGNAL TRANSDUCTION IN TOMATO

Frontiers of Agricultural Science and Engineering 2021, Volume 8, Issue 2,

Abstract: Leaflet wounding also activated electrical signal transduction and jasmonic acid (JA) signaling withinIt was also demonstrated that tomato glutamate receptor-like 3.3 (GLR3.3) and GLR3.5 mediated leaflet-to-leaflet

Keywords: electrical signal / glutamate receptor-like / herbivory / jasmonic acid / tomato    

Continuous biohydrogen production from diluted molasses in an anaerobic contact reactor

Sheng CHANG, Jianzheng LI, Feng LIU

Frontiers of Environmental Science & Engineering 2011, Volume 5, Issue 1,   Pages 140-148 doi: 10.1007/s11783-010-0258-2

Abstract: The results showed that a stable ethanol-type fermentation that favored hydrogen production in the reactorfound that the ethanol increased more than other liquid fermentation products, and the ethanol/acetic acid

Keywords: fermentative hydrogen production     anaerobic contact reactor (ACR)     sludge loading rate (SLR)     butyric acid-typefermentation     ethanol-type fermentation    

A new procedure combining GC-MS with accelerated solvent extraction for the analysis of phthalic acid

Tingting MA, Ying TENG, Peter CHRISTIE, Yongming LUO, Yongshan CHEN, Mao YE, Yujuan HUANG

Frontiers of Environmental Science & Engineering 2013, Volume 7, Issue 1,   Pages 31-42 doi: 10.1007/s11783-012-0463-2

Abstract: GC-MS) combined with accelerated solvent extraction (ASE) is developed for the analysis of six phthalic acid

Keywords: phthalic acid esters     quality assurance and quality control     soil type     accelerated solvent extraction     certified    

Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate cells

Ling YANG, Rui ZHU, Qingjing ZHU, Dan DAN, Jin YE, Keshu XU, Xiaohua HOU

Frontiers of Medicine 2009, Volume 3, Issue 1,   Pages 36-40 doi: 10.1007/s11684-009-0020-y

Abstract: influence of β-elemene on the secretion of angiotensin II (ANG II) and the expression of angiotensin receptortype 1 (AT1R) in hepatic stellate cells (HSCs)

Keywords: liver cirrhosis     beta-elemene     hepatic stellate cells     angiotensin II     receptor     angiotensin     type 1    

Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases

Chong Liu, Dingfeng Su

Frontiers of Medicine 2012, Volume 6, Issue 1,   Pages 35-40 doi: 10.1007/s11684-012-0171-0

Abstract: cholinergic anti-inflammatory pathway,” more specifically via the α7 nicotinic acetylcholine receptor

Keywords: α7 nicotinic acetylcholine receptor     cardiovascular diseases     baroreflex sensitivity    

Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies

Peter B. Alexander,Xiao-Fan Wang

Frontiers of Medicine 2015, Volume 9, Issue 2,   Pages 134-138 doi: 10.1007/s11684-015-0396-9

Abstract: In this review, we discuss the main known mechanisms of resistance to receptor tyrosine kinase inhibitorsoutput, and consider the problems of signaling pathway redundancy and how the activation of different receptor

Keywords: targeted therapy     drug resistance     receptor tyrosine kinases     cancer    

Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factorreceptor 2-negative (HR

Wenjie Zhu, Binghe Xu

Frontiers of Medicine 2021, Volume 15, Issue 2,   Pages 208-220 doi: 10.1007/s11684-020-0795-4

Abstract: New targeted therapies have been developed to overcome resistance to endocrine therapy (ET) and improve the outcome of HR /HER2 advanced breast cancer (ABC). We conducted a meta-analysis and systemic review on randomized controlled trials evaluating various targeted therapies in combination with ET in HR /HER2 ABC. PUBMED and EMBASE databases were searched for eligible trials. Hazard ratios (HRs) for progression-free survival (PFS), odds ratios (ORs) for objective response rate (ORR), clinical benefit rate (CBR), and toxicity were meta-analyzed. Twenty-six studies with data on 10 347 patients were included and pooled. The addition of cyclin-dependent kinase 4/6 inhibitors to ET significantly improved median PFS (pooled HR= 0.547, <0.001), overall survival (pooled HR= 0.755, <0.001), and tumor response rates (ORR, pooled OR= 1.478, <0.001; CBR, pooled OR= 1.201, <0.001) with manageable toxicities (pooled OR= 3.280, <0.001). The mammalian targets of rapamycin inhibitors and exemestane were not clinically beneficial for this pooled population including ET-naïve and ET-resistant patients. Moderate improvement in PFS (pooled HR= 0.686, <0.001) yet pronounced toxicities (pooled OR= 2.154, <0.001) were noted in the combination of phosphatidylinositol-4,5-bisphosphate 3-kinase inhibitors with fulvestrant. Future studies are warranted to optimize the population and the dosing sequence of these available options.

Keywords: endocrine-resistant     HR+/HER2- advanced breast cancer     randomized clinical trials     meta-analysis     targeted therapy    

microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor

Frontiers of Medicine 2023, Volume 17, Issue 4,   Pages 699-713 doi: 10.1007/s11684-022-0972-8

Abstract: Anti-CD19 chimeric antigen receptor (CAR)-T cell therapy has achieved 40%–50

Keywords: anti-CD19 chimeric antigen receptor T     immunotherapy     diffuse large B cell lymphoma     tumor microenvironment    

Chimeric antigen receptor T cell therapies for acute myeloid leukemia

Bin Gu, Jianhong Chu, Depei Wu

Frontiers of Medicine 2020, Volume 14, Issue 6,   Pages 701-710 doi: 10.1007/s11684-020-0763-z

Abstract: Abstract Chimeric antigen receptor T cell (CAR T) therapies have achieved unprecedented efficacy in B-cell

Keywords: acute myeloid leukemia     CAR T     immunotherapy    

Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy

Zhao Zhang, Jun Jiang, Xiaodong Wu, Mengyao Zhang, Dan Luo, Renyu Zhang, Shiyou Li, Youwen He, Huijie Bian, Zhinan Chen

Frontiers of Medicine 2019, Volume 13, Issue 1,   Pages 57-68 doi: 10.1007/s11684-019-0683-y

Abstract: In recent years, the development of tumor immunotherapy especially chimeric antigen receptor T (CAR-TEpidermal growth factor receptor variant III (EGFRvIII) is a tumor-specific mutation expressed in various

Keywords: chimeric antigen receptor T cells     epidermal growth factor receptor     lung cancer     immunotherapy     tumor immunolog    

Title Author Date Type Operation

Putative Mode of Action of the Monoterpenoids Linalool, Methyl Eugenol, Estragole, and Citronellal on Ligand-Gated Ion Channels

Amy S. Li, Akimasa Iijima, Junhao Huang, Qing X. Li, Yongli Chen

Journal Article

Protective effects of nicotine on gamma-aminobutyric acid neurons and dopaminergic neurons in mice with

Lei FU MD , Dezheng GONG BM , Yan PENG , Dongmei WANG BM , Hong XU , Yue LI MD , Dengqin YU BS , Yanhui FENG MD , Shengming YIN PhD , Jin GONG , Yiping SUN PhD ,

Journal Article

Plasma soluble C-type lectin-like receptor-2 is associated with the risk of coronary artery disease

Min Fei, Li Xiang, Xichen Chai, Jingchun Jin, Tao You, Yiming Zhao, Changgeng Ruan, Yiwen Hao, Li Zhu

Journal Article

Chemotactic effect of urokinase-type plasminogen activator on mouse spermatozoa

DING Xiaofang, LI Honggang, XIONG Chengliang

Journal Article

Bioactive hyaluronic acid fragments inhibit lipopolysaccharide-induced inflammatory responses via theToll-like receptor 4 signaling pathway

Na You, Sasa Chu, Binggang Cai, Youfang Gao, Mizhou Hui, Jin Zhu, Maorong Wang

Journal Article

CHARACTERISTICS OF HERBIVORY/WOUND-ELICITED ELECTRICAL SIGNAL TRANSDUCTION IN TOMATO

Journal Article

Continuous biohydrogen production from diluted molasses in an anaerobic contact reactor

Sheng CHANG, Jianzheng LI, Feng LIU

Journal Article

A new procedure combining GC-MS with accelerated solvent extraction for the analysis of phthalic acid

Tingting MA, Ying TENG, Peter CHRISTIE, Yongming LUO, Yongshan CHEN, Mao YE, Yujuan HUANG

Journal Article

Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate cells

Ling YANG, Rui ZHU, Qingjing ZHU, Dan DAN, Jin YE, Keshu XU, Xiaohua HOU

Journal Article

Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases

Chong Liu, Dingfeng Su

Journal Article

Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies

Peter B. Alexander,Xiao-Fan Wang

Journal Article

Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factorreceptor 2-negative (HR

Wenjie Zhu, Binghe Xu

Journal Article

microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor

Journal Article

Chimeric antigen receptor T cell therapies for acute myeloid leukemia

Bin Gu, Jianhong Chu, Depei Wu

Journal Article

Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy

Zhao Zhang, Jun Jiang, Xiaodong Wu, Mengyao Zhang, Dan Luo, Renyu Zhang, Shiyou Li, Youwen He, Huijie Bian, Zhinan Chen

Journal Article